Qnovia

Digital

Health Innovators – Brian Quigley and Mario Danek (Live from...

At HLTH last month, pharmaphorum Editor in Chief Jonah Comstock sat down with the CEO and CTO respectively of QNovia, Brian Quigley and Mario Danek.

News

Andexxa reaches the end of the line in the US

AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Editor's Picks